Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Harvard Business School

Generated: June 29, 2017

DrugPatentWatch Database Preview

HUMALOG MIX 50/50 PEN Drug Profile

« Back to Dashboard

Which patents cover Humalog Mix 50/50 Pen, and what generic Humalog Mix 50/50 Pen alternatives are available?

Humalog Mix 50/50 Pen is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HUMALOG MIX 50/50 PEN is insulin lispro protamine recombinant; insulin lispro recombinant. There are thirty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin lispro protamine recombinant; insulin lispro recombinant profile page.

Summary for Tradename: HUMALOG MIX 50/50 PEN

Suppliers / Packagers: see list1
Clinical Trials: see list312
Drug Prices:see details
DailyMed Link:HUMALOG MIX 50/50 PEN at DailyMed

Pharmacology for Tradename: HUMALOG MIX 50/50 PEN

Drug ClassInsulin Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
insulin lispro protamine recombinant; insulin lispro recombinant
INJECTABLE;INJECTION021018-003Dec 22, 1999DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Argus Health
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus